Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06820164 · ClinicalTrials.gov registry record · Phase 1

Lipomas Treated with Subcutaneous Injections of Cooled Sodium Chloride

A Phase 1 study of Lipoma, sponsored by West Virginia University.

Recruiting
Registry status
Phase 1
Development phase
20
Enrollment target
1
Study location

NCT06820164 is a Phase 1 study of Lipoma that is actively recruiting participants, run by West Virginia University. The registered enrollment target is 20 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06820164, a Phase 1 study of Lipoma, is actively recruiting participants, sponsored by West Virginia University.

RECRUITING
Registry status
Phase 1
Development phase
20 participants
Enrollment target
1
Study location

Study Summary

Lipomas are benign tumors composed of mature adipose tissue. While harmless, these are the most common type of soft tissue growths with some patients developing numerous lipomas. Patients often seek removal for cosmesis, or symptoms caused by location and/or compression of surrounding structures. This exploratory study aims to evaluate the effectiveness of subcutaneous injections of cooled normal saline as a treatment option for lipomas. The study will assess whether this technique could serve as a viable alternative to existing treatment options, especially compared to topically applied fat-freezing devices. The Investigators propose that this method may offer a more comfortable nonsurgical option for targeted fat reduction, as the cold temperatures are applied directly to the lipomas.

Conditions Studied

Interventions

  • DRUG Cooled Sodium Chloride Injection

Study Locations (1)

West Virginia

  • West Virginia University - Morgantown

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2025-03
Est. Completion 2026-01
Phase Phase 1

Sponsor

West Virginia University

122 total trials

What the Registry Record Tells You About NCT06820164

The ClinicalTrials.gov registry entry for NCT06820164 describes a study currently listed as recruiting, categorized as Phase 1. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is West Virginia University, which has 122 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Lipoma appearing as the primary indexed condition, and to 1 intervention - of which Cooled Sodium Chloride Injection is the first listed.

NCT06820164 reports 1 study location spanning 1 distinct geographic area - top geographies include West Virginia.

Frequently Asked Questions

What is clinical trial NCT06820164 about?

NCT06820164 is a clinical study titled "Lipomas Treated with Subcutaneous Injections of Cooled Sodium Chloride". Lipomas are benign tumors composed of mature adipose tissue. While harmless, these are the most common type of soft tissue growths with some patients developing numerous lipomas. Patients often seek removal for cosmesis, or symptoms caused by location and/or compression of surrounding structures. Th...

What is the current status of trial NCT06820164?

This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 20 participants. The study started on 2025-03. Estimated completion is 2026-01.

What conditions does trial NCT06820164 study?

This clinical trial studies the following conditions: Lipoma.

What interventions are being tested in trial NCT06820164?

The interventions under investigation include: Cooled Sodium Chloride Injection (DRUG).

Who is sponsoring clinical trial NCT06820164?

This trial is sponsored by West Virginia University, which has 122 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06820164 being conducted?

This trial has 1 study location across West Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Lipoma

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.